HL
CLB icon

Harding Loevner’s Core Laboratories CLB Stock Holding History

Harding Loevner’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-124,004
Closed -$2.73M – 72
2023
Q1 		$2.73M Buy
124,004
+4,417
+4% +$103K 0.02% 71
2022
Q4 		$2.42M Sell
119,587
-3,635
-3% -$70.5K 0.01% 79
2022
Q3 		$1.66M Buy
123,222
+7,543
+7% +$127K 0.01% 76
2022
Q2 		$2.29M Buy
115,679
+3,691
+3% +$98.1K 0.01% 76
2022
Q1 		$2.71M Buy
111,988
+8,453
+8% +$237K 0.01% 79
2021
Q4 		$2.31M Hold
103,535
– – 0.01% 81
2021
Q3 		$2.87M Buy
103,535
+1,691
+2% +$51.5K 0.01% 81
2021
Q2 		$3.97M Buy
101,844
+11,373
+13% +$408K 0.01% 78
2021
Q1 		$2.6M Buy
90,471
+944
+1% +$32.2K 0.01% 81
2020
Q4 		$2.37M Buy
89,527
+5,375
+6% +$110K 0.01% 73
2020
Q3 		$1.28M Sell
84,152
-1,064
-1% -$22.3K ﹤0.01% 105
2020
Q2 		$1.73M Sell
85,216
-87,650
-51% -$1.57M 0.01% 72
2020
Q1 		$1.79M Buy
172,866
+29,783
+21% +$833K 0.01% 79
2019
Q4 		$5.39M Sell
143,083
-14,736
-9% -$662K 0.02% 72
2019
Q3 		$7.36M Buy
157,819
+70,749
+81% +$3.29M 0.03% 70
2019
Q2 		$4.55M Buy
87,070
+44,088
+103% +$2.59M 0.02% 71
2019
Q1 		$2.96M Buy
42,982
+10,249
+31% +$687K 0.01% 71
2018
Q4 		$1.95M Buy
32,733
+21,020
+179% +$1.81M 0.01% 72
2018
Q3 		$1.36M Sell
11,713
-849
-7% -$95.8K 0.01% 72
2018
Q2 		$1.58M Buy
+12,562
New +$1.53M 0.01% 70
2016
Q3 		– Sell
-15
Closed -$2K – 89
2016
Q2 		$2K Hold
15
– – ﹤0.01% 84
2016
Q1 		$2K Buy
15
+14
+1,400% +$1.45K ﹤0.01% 86
2015
Q4 		$0 Buy
+1
New +$114 ﹤0.01% 103

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Harding Loevner's CLB Position: Q2 2023 in Review

Harding Loevner sold out of Core Laboratories (CLB) in Q2 2023, closing a stake of 124,004 shares — an estimated $2.73M sold.

Harding Loevner first reported a position in CLB in Q4 2015 and held it in 23 quarters. The position peaked at $7.36M in Q3 2019. 164 funds tracked by Wall St. Rank hold CLB as of Q2 2023.

  • Harding Loevner reported no remaining Core Laboratories position as of Q2 2023 after selling out during the quarter.
  • Harding Loevner sold 124,004 Core Laboratories shares in Q2 2023, an estimated $2.73M.
  • Harding Loevner first reported a position in Core Laboratories in Q4 2015 and held it in 23 quarters.
  • Harding Loevner's Core Laboratories position peaked at $7.36M in Q3 2019.
  • 164 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2023.

Based on Harding Loevner's 13F filing for Q2 2023, filed 14 Aug 2023.